Atypical erythema multiforme type-like pityriasis rosea

Eleni Klimi

Department of Dermatology, Thriassio General Hospital Magula Athens, Greece

Corresponding author: Eleni Klimi, MD, E-mail: eklimi2018@gmail.com

How to cite this article: Klimi E. Atypical erythema multiforme type-like pityriasis rosea. Our Dermatol Online. 2024;15(3):310-311.
Submission: 13.11.2023; Acceptance: 14.05.2024
DOI: 10.7241/ourd.20243.21

Citation tools: 

Related Content

Copyright information

© Our Dermatology Online 2024. No commercial re-use. See rights and permissions. Published by Our Dermatology Online.


A 47-year-old female consulted for a pruritic eruption consisting of targetoid lesions with a peripheral scaling collarette that appeared five days prior to consultation. The lesions presented a symmetrical distribution on both upper and lower limbs and on the buttocks (Figs. 1a1c). Neither a herald patch nor lesions on the trunk was observed. The oral and genital mucosae were intact. Neither fever nor deterioration of the general health was reported. Based on the clinical examination, the most probable diagnosis was atypical erythema multiforme type-like pityriasis rosea.

Figure 1: (a) Symmetrical lesions of pityriasis rosea on both arms (erythema multiforme type-like). (b) Lesions of pityriasis rosea on the posterior surfaces of both lower limbs. (c) Lesions of pityriasis rosea on both buttocks and legs.

Pityriasis rosea is a papulosquamous eruption characterized by papules and plaques with a peripheral scaling and a Christmas tree-like distribution on the trunk preceded by a herald patch in its typical form, while atypical variants have also been described [1]. Herpes 6 and 7 viruses and COVID-19 virus have been implicated in its etiopathogenesis [2]. Pityriasis rosea in both the typical and atypical forms is a self-limiting condition regressing without sequelae.

The final diagnosis was atypical erythema multiforme type-like pityriasis rosea. The differential diagnoses were psoriasis guttate, erythema multiforme, and lichenoid pityriasis.

Consent

The examination of the patient was conducted according to the principles of the Declaration of Helsinki.

The authors certify that they have obtained all appropriate patient consent forms, in which the patients gave their consent for images and other clinical information to be included in the journal. The patients understand that their names and initials will not be published and due effort will be made to conceal their identity, but that anonymity cannot be guaranteed.

REFERENCES

1. Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. World J Clin Cases. 2017;5:203-11.

2. Klimi E, Vasdeki D. Acral purpura and pityriasis rosea-like eruption following COVID-19 infection. Our Dermatology Online. 2022:324-5.

Source of Support: This article has no funding source.

Conflict of Interest: The authors have no conflict of interest to declare.

Request permissions
If you wish to reuse any or all of this article please use the e-mail (contact@odermatol.com) to contact with publisher.

Related Content:

Related Articles Search Authors in

http://orcid.org/0000-0001-5113-5640

Comments are closed.